Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.
Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.
Calypso Biotech is a biotech company developing antibody therapies up to clinical proof-of-concept by leveraging its expertise in immunology and drug development. Calypso Biotech’s portfolio consists of two therapeutic antibody programs planned to reach the clinic by 2016-2017 against gastro-intestinal auto-immune syndromes such as Crohn’s and Refractory Celiac diseases.
BioMarin is a biotech company focusing on the delivery of first-to-market therapies for patients with rare genetic diseases.